Skip to main content
SpringerLink
Log in

Combined Use of Nitric Oxide and Nitric Oxide Synthase Inhibitors as a Possible Therapeutic Approach

  • Chapter
Nitric Oxide in Pulmonary Processes

Part of the book series: Respiratory Pharmacology and Pharmacotherapy ((RPP))

  • 81 Accesses

Abstract

Since the discovery in 1987 that endothelium-derived relaxant factor (EDRF) is identical to the gaseous mediator nitric oxide (NO), we have learned that NO serves as a ubiquitous signalling molecule in the cardiovascular, central nervous and immune systems. NO regulates vascular tone and prevents the adhesion of blood-borne cells to the endothelium. In the lung, the formation of NO by the NO synthase (NOS) located in the endothelium (eNOS) helps to maintain a low vascular resistance and acts to oppose hypoxic pulmonary vasoconstriction. An enhanced formation of NO following the induction of the inducible isoform of NOS (iNOS), however, contributes to the pathophysiology of several diseases including circulatory shock. Although the inhibition of NO formation with agents which non-selectively inhibit all isoforms of NOS exerts some beneficial effects (due to the inhibition of iNOS activity), they also exert side effects, which are secondary to the inhibition of eNOS activity. Using circulatory shock as one example of a disease associated with a significant overproduction of NO, this article reviews the effects and side effects of pharmacological approaches aimed at enhancing (e.g. NO gas, NO donors) or reducing (NOS inhibitors) the formation and/or availability of NO. In addition, results of therapeutic approaches designed to limit the side effects of non-selective inhibitors of NOS activity by combining these agents with either the administration of NO donors or NO inhalation will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2202–2212

    Google Scholar 

  2. Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051–3064

    PubMed  CAS  Google Scholar 

  3. Dinerman JL, Lowenstein CJ, Snyder SH (1993) Molecular mechanism of nitric oxide regulation: potential relevance to cardiovascular disease. Circ Res 73: 217–222

    Article  PubMed  CAS  Google Scholar 

  4. Morris SM, Billiar TR (1994) New insights into the regulation of inducible nitric oxide synthase. Am J Physiol 266: E829–839

    PubMed  CAS  Google Scholar 

  5. Thiemermann C (1994) The role of L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol 28: 45–79

    Article  PubMed  CAS  Google Scholar 

  6. Szabo C, Thiemermann C (1994) Role of nitric oxide in haemorrhage, traumatic and anaphylactic shock, and thermal injury. Shock 2: 145–155

    Article  PubMed  CAS  Google Scholar 

  7. Loscalzo J, Welch G (1995) Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 38: 87–104

    Article  PubMed  CAS  Google Scholar 

  8. Sprague RS, Thiemermann C, Vane JR (1992) Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anaesthetized rabbits. Proc Natl Acad Sci USA 89: 8711–8715

    Article  PubMed  CAS  Google Scholar 

  9. Thiemermann C, Vane JR (1990) Inhibition of nitric oxide synthesis reduces the hypotention induced by bacterial lipopolysaccharide in the rat. Eur J Pharmacol 182: 591–595

    Article  PubMed  CAS  Google Scholar 

  10. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC (1990) Loss of vascular responsiveness induced by endotoxin involves the L-arginine pathway. Am J Physiol 259: H1038–H1043

    PubMed  CAS  Google Scholar 

  11. Rees DD, Celleck S, Palmer RMJ, Moncada S (1990) Dexamethasone prevents the induction of nitric oxide synthase and the associated effects on the vascular tone: an insight into endotoxic shock. Biochem Biophys Res Commun 173: 541–547

    Article  PubMed  CAS  Google Scholar 

  12. Kilboum RG, Juburan A, Gross SS, Griffith OW, Levi R, Adams J et al (1990) Reversal of endotoxin-mediated shock by NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172: 1132–1138

    Article  Google Scholar 

  13. Kilbourn RG, Gross SS, Jubran A, Adams J, Griffith OW, Levi Rat al (1990) NG-methyl-Larginine inhibits tumour necrosis factor-induced hypotension: implications for the involement of nitric oxide. Proc Natl Acad Sci USA 87: 62932

    Article  Google Scholar 

  14. Curran RD, Ferrari FK, Kispert KH, Stadler J, Stuchr DJ, Simmons RL et al (1991) Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J 5: 2085–2095

    PubMed  CAS  Google Scholar 

  15. Billiar TR, Curran RD, Harbrecht BG, Stuchr DJ, Demetris AJ, Simmons RL (1990) Modulation of nitric oxide synthesis in vivo. NG-monomethyl-L-arginine endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 48: 565–569

    PubMed  CAS  Google Scholar 

  16. Szabo C, Mitchell JA, Thiemermann C, Vane JR (1993) Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 108: 786–792

    Article  PubMed  CAS  Google Scholar 

  17. MacMicking JD, Nathan C, Horn G, Chartrain N, Fletcher DS, Trumbauer M et al (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 82: 641–650

    Article  Google Scholar 

  18. Parratt JR, Stoclet JC (1995) Vascular smooth muscle function under conditions of sepsis and endotoxaemia. In: Firik MP, Payen D (eds) Role of nitric oxide in sepsis and ARDS. Berlin: Springer, 44–61

    Chapter  Google Scholar 

  19. Thiemermann C (1995) Inhibition of nitric oxide synthase activity in circulatory shock: Friend or Foe? In: Fink MP, Payen D (eds) Role of nitric oxide in sepsis and ARDS. Berlin: Springer, 201–216

    Chapter  Google Scholar 

  20. Baue AE (1983) The multiple organ or systems failure syndrome. In: Schlag G, Redl H (eds). Pathophysiology of shock, sepsis and organ failure. Berlin: Springer, 1004–1018

    Google Scholar 

  21. Bone RC (1994) Gram-positive organism and sepsis. Arch Intern Med 154: 26–34

    Article  PubMed  CAS  Google Scholar 

  22. Schraufstatter L, Hinshaw D, Hyslop P, Spragg R, Cochrane C (1986) Oxidant injury of cells. DNA strand breaks activate polyadenosine diphosphate ribose polymerase and lend to depletion of nicotinamide adenine dinucleotide. J Clin Invest 77: 1312–1319

    Article  PubMed  CAS  Google Scholar 

  23. Zingarelli B, O’Conner M, Wong H, Salzman AL, Szabo C (1996) Peroxynitrite-mediated DNA breakage activates polyadenosine diphosphate ribosyl sythetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J Immunol 156: 350–358

    PubMed  CAS  Google Scholar 

  24. Thiemermann C, Ruetten H, Wu CC, Vane JR (1995) The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116: 2845–2851

    Article  PubMed  CAS  Google Scholar 

  25. Ruetten H, Southan GJ, Abate A, Thiemermann C (1996) Attenuation of the multiple organ dysfunction caused by endotoxin by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br JPharmacol 118: 261–270

    Article  CAS  Google Scholar 

  26. Szabo C, Thiemermann C (1995) Regulation of the expression of the inducible isoform of nitric oxide synthase. Adv Pharmacol 34: 113–154

    Article  PubMed  CAS  Google Scholar 

  27. Moore PK, Al-Swayeh OH, Chong NWS, Evans RA, Gibson A (1990) L-N-nitro-arginine, a novel, L-arginine reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol 99: 408–412

    Article  CAS  Google Scholar 

  28. Cobb JP, Danner RL (1996) Nitric oxide and septic shock. JAMA 275: 1192–1196

    Article  PubMed  CAS  Google Scholar 

  29. Wright CE, Rees DD, Moncada S (1991) Protective and pathological roles of nitric oxide in endotoxic shock. Cardiovasc Res 26: 48–57

    Article  Google Scholar 

  30. Park JH, Chang SH, Lee KM, Shin SH (1996) Protective effect of nitric oxide in an endotoxin-induced septic shock. Am J Surg 171: 340–345

    Article  PubMed  CAS  Google Scholar 

  31. Southan GJ, Szabo C (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51: 383–394

    Article  PubMed  CAS  Google Scholar 

  32. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR, Williamson JR, McDaniel ML (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552–558

    Article  PubMed  CAS  Google Scholar 

  33. Misko TP, Moore WM, Kasten TP, Nickols DA, Corbett JA, Tilton RG et al (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233: 119–125

    Article  PubMed  CAS  Google Scholar 

  34. Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR (1995) Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 114: 1666–1672

    Article  PubMed  CAS  Google Scholar 

  35. Wu CC, Ruetten H, Thiemermann C (1996) Comparison of the effects of aminoguanidine and NG-nitro-L-arginine methyl esteron the multiple organ dysfunction caused by endotoxaemia in the rat. Eur J Pharmacol 300: 99–104

    Article  PubMed  CAS  Google Scholar 

  36. Garvey PE, Oplinger JA, Tanoury GJ, Sherman PA, Fowler M, Marshall S et al (1994) Potent and selective inhibition of human nitric oxide syntheses. Inhibition by non-amino acid isothioureas. J Biol Chem 269: 26669–26676

    PubMed  CAS  Google Scholar 

  37. Szabo C, Southan G, Thiemermann C (1994) Beneficial effects and improved survival in rodent models of septic shock with S-methyl-isothiourea sulfate, a novel, potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91: 12472–12476

    Article  PubMed  CAS  Google Scholar 

  38. Sontham G, Szabo C, Thiemermann C (1995) Isothioureas: potent inhibitors of nitric oxide syntheses with variable isoform selectivity. Br JPharmacol 114: 510–516

    Google Scholar 

  39. Sontham GJ, Szabo C (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51: 383–394

    Article  Google Scholar 

  40. Southan GJ, Szabo C, O’Conner MP, Salzman AC, Thiemermann C (1996) Amidines are potent inhibitors of constitutive and inducible nitric oxide syntheses: Preferential inhibition of the inducible isoform. Eur JPharmacol 291: 311–318

    Google Scholar 

  41. Zhang H, Rogiers P, Friedman G, Prelser JC, Spapen H, Buurman WA, Vincent JL (1996) Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endotoxic shock. Arch Surg 11: 767–774

    Article  Google Scholar 

  42. Pastor CM, Payen DM (1994) Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 2: 196–202

    Article  PubMed  CAS  Google Scholar 

  43. Pastor CM, Losser MR, Payen D (1995) Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology 22: 1547–1553

    PubMed  CAS  Google Scholar 

  44. Weitzberg E, Rudehill A, Lundberg JM (1993) Nitric oxide inhaltion attenuates pulmonary hypertension and improves gas exchange in endotoxic shock. Eur J Pharmacol 233: 85–94

    Article  PubMed  CAS  Google Scholar 

  45. Dalim P, Blomquist S, Martensson L, Thorne J, Zoucas E (1994) Circulatory and ventilatory effects of intermittent nitric oxide inhalation during porcine endotoxaemia. J Trauma 37: 769–777

    Article  Google Scholar 

  46. Offner PJ, Ogura H, Jordan BS, Pruitt BA, Cioffi WG (1995) Effects of inhaled nitric oxide on right ventricular function in endotoxin shock. J Trauma 39: 179–185

    Article  PubMed  CAS  Google Scholar 

  47. Klemm P, Thiemermann C, Winkimaler G, Martorana PA, Henning R (1995) Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxic shock. Br J Pharmacol 114: 363–368

    Article  PubMed  CAS  Google Scholar 

  48. Weitzberg E, Rudehill A, Modin A, Lundberg JM (1995) Effect of combined nitric oxide inhalation and N°-nitro-L-arginine infusion in procine endotoxin shock. Crit Care Med 23: 909–918

    Article  PubMed  CAS  Google Scholar 

  49. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Valiance P (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28: 34–39

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The William Harvey Research Institute, St. Bartholomew’s Medical College, Charterhouse Square, London, EC1M 6BQ, UK

    Christoph Thiemermann

Authors
  1. Christoph Thiemermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmacology Department, Rhône-Poulenc Rorer Research & Development, Rainham Road South, Dagenham, Essex, RM 10 7XS, UK

    Maria G. Belvisi

  2. Unit of Critical Care Medicine Imperial College Medical School, Royal Brompton Hospital, Sidney Street, London, SW3 6NP, UK

    Jane A. Mitchell

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Basel AG

About this chapter

Cite this chapter

Thiemermann, C. (2000). Combined Use of Nitric Oxide and Nitric Oxide Synthase Inhibitors as a Possible Therapeutic Approach. In: Belvisi, M.G., Mitchell, J.A. (eds) Nitric Oxide in Pulmonary Processes. Respiratory Pharmacology and Pharmacotherapy. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8474-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8474-7_12

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9582-8

  • Online ISBN: 978-3-0348-8474-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation